Related Experiment Video
Updated: Jul 18, 2026
06:43
Quantitative Analysis and Characterization of Atherosclerotic Lesions in the Murine Aortic Sinus
Published on: December 7, 2013
Analytical models of atherosclerosis
13W Consulting Company, 61 Houghton St. No. 5, Worcester, MA 01604, USA. harriswang@yahoo.com
Atherosclerosis
|November 2, 2001
Summary
Atherosclerosis lesion formation is linked to thicker boundary layers and lower surface adhesion at arterial branches. This study enhances understanding of cardiovascular disease mechanisms.
Area of Science:
- Cardiovascular Science
- Biomedical Engineering
- Thermodynamics
Background:
- Atherosclerosis accounts for 50% of global mortalities.
- Understanding initial atherosclerotic lesion formation is critical.
Purpose of the Study:
- To investigate atherosclerotic lesion development using novel thermodynamic and boundary value models.
- To analyze the role of arterial branch points in early lesion formation.
Main Methods:
- Developed and applied a thermodynamic model.
- Utilized a boundary value model for analysis.
- Employed an analytical example of a human abdominal aorta with an initial lesion.
Main Results:
- Identified increased transient boundary layer thickness at arterial branch points.
- Found reduced surface energy of adhesion in these regions.
- These factors are proposed as crucial for initial lesion formation.
Conclusions:
- The study provides insights into the mechanisms of atherosclerosis.
- Findings aid in interpreting clinical and experimental results related to cardiovascular disease.
Related Concept Videos
01:38Inflammation
Overview
01:30Coronary Artery Disease I: Introduction
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
01:26Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
01:30Atherosclerosis I: Introduction
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
01:27Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...